Cetera Advisors LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 699 shares of the medical equipment provider’s stock after selling 87 shares during the period. Cetera Advisors LLC’s holdings in Intuitive Surgical were worth $398,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund raised its position in shares of Intuitive Surgical by 31,963.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 14,679,377 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 14,633,595 shares during the last quarter. Stone House Investment Management LLC bought a new stake in Intuitive Surgical in the first quarter valued at about $31,000. Laurel Wealth Advisors LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at about $32,000. Athena Capital Advisors LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at about $33,000. Finally, Ellis Investment Partners LLC bought a new stake in Intuitive Surgical in the first quarter valued at about $34,000. 84.85% of the stock is owned by institutional investors and hedge funds.
In other news, CEO Gary S. Guthart sold 22,636 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $501.48, for a total transaction of $11,351,501.28. Following the sale, the chief executive officer now directly owns 386,866 shares of the company’s stock, valued at $194,005,561.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Lonnie M. Smith sold 210 shares of the stock in a transaction that occurred on Tuesday, February 26th. The shares were sold at an average price of $546.56, for a total transaction of $114,777.60. Following the sale, the director now directly owns 359,246 shares in the company, valued at $196,349,493.76. The disclosure for this sale can be found here. Insiders have sold 32,493 shares of company stock worth $16,563,270 over the last ninety days. Insiders own 1.70% of the company’s stock.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.70 by ($0.09). The firm had revenue of $974.00 million for the quarter, compared to the consensus estimate of $975.27 million. Intuitive Surgical had a return on equity of 17.33% and a net margin of 29.78%. Intuitive Surgical’s quarterly revenue was up 14.9% compared to the same quarter last year. During the same period in the prior year, the company posted $2.44 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 9.4 EPS for the current fiscal year.
A number of analysts recently weighed in on ISRG shares. Cantor Fitzgerald set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Thursday, April 4th. Deutsche Bank started coverage on shares of Intuitive Surgical in a research note on Monday, April 1st. They issued a “buy” rating and a $630.00 target price on the stock. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, January 30th. Stifel Nicolaus lowered their target price on shares of Intuitive Surgical from $600.00 to $570.00 and set a “buy” rating on the stock in a research note on Friday, January 25th. Finally, Canaccord Genuity reissued a “buy” rating and issued a $575.00 target price (down previously from $610.00) on shares of Intuitive Surgical in a research note on Monday, April 22nd. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $576.82.
WARNING: This article was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/20/intuitive-surgical-inc-isrg-shares-sold-by-cetera-advisors-llc.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Article: What is an overbought condition?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.